Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities

Hepatocellular carcinoma (HCC) is an aggressive malignancy, and most patients are diagnosed at intermediate or advanced stages. Targeted therapies, immunotherapies, and combination regimens have limited efficacy, creating a major clinical challenge. The phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway...

Zhi-Bo Zhang, Jie Liu, Guo-Feng Lei et al. · 0 citations
Review Open access Aug 2026

PI3K/AKT signaling pathway: molecular crossroads in tumorigenesis and therapeutic innovation

This study comprehensively investigates PI3K/AKT signaling, elucidating its involvement across diverse human systemic tumors and analyzing the interplay between this pathway and other signaling cascades implicated in tumorigenesis.

Qingmiao Shi, Jie Liu, Qing-Fei Chu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.